Tokyo, March 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060989) titled 'Study of real-world treatment before and after surgery for people with HER2-positive breast cancer' on March 24.
Study Type:
Observational
Primary Sponsor:
Institute - Prime Research Institute for Medical RWD, Inc.
Condition:
Condition - HER2-positive breast cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To describe perioperative treatment patterns and treatment outcomes in HER2-positive breast cancer patients stratified by stage using J-CONNECT registry data.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit -...